The clinical and Virology effects of NA inhibitor in influenza virus infections (age; over 4 years old, under 11 years old): an open-label, randomized study.
Not Applicable
- Conditions
- Childhood influenza infections
- Registration Number
- JPRN-UMIN000010024
- Lead Sponsor
- Hirotsu Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
History of hypersensitivity caused by neuraminidase inhibitors. Patients who are deemed to be inappropriate by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method -Time to return to normal body temperature (under 37.5 degrees) -Influenza virus titer (TCID50)
- Secondary Outcome Measures
Name Time Method -Duration of influenza symptoms patients -IC50 in NA inhibition assays of NA inhibitors -Virus mutation after treatment of NA inhibitors